Our findings revealed that rs6474526 variants were significantly associated with larger tumor sizes and distant metastases of LUAD in female and non-smoking groups, suggesting that this ADAM9 SNP may serve as a useful predictor of disease progression in both LUAD populations. Here, ADAM9 is linked to neoplasm.